CFS/ME is a relatively common clinical condition, which can cause profound, often prolonged, illness and disability, and can have a substantial impact on the individual and the family. It affects all ages (adults and children), ethnic groups and social classes.

Nationally up to 240,000 people (0.2 – 0.4% population) are affected by CFS/ME. The estimated costs to the community are £3,467m/year. Cost per person is £14,746/year of which medical costs nationally are around £210m/yr (£896 per person), and public purse costs – benefits and lost taxation – £2,222m/yr nationally, consisting mainly of benefits (£4800/person/year) costs and lost taxation (£4100/person/year)

For a more information regarding our Spasticity Management Programme please download our Spasticity Management Brochure.